Share on StockTwits

Varian Medical Systems (NYSE:VAR) CFO Elisha W. Finney sold 15,000 shares of the stock on the open market in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $81.66, for a total value of $1,224,900.00. Following the transaction, the chief financial officer now directly owns 4,496 shares of the company’s stock, valued at approximately $367,143. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Varian Medical Systems (NYSE:VAR) traded up 1.82% on Monday, hitting $83.38. The stock had a trading volume of 455,052 shares. Varian Medical Systems has a one year low of $70.10 and a one year high of $87.85. The stock’s 50-day moving average is $83.9 and its 200-day moving average is $82.54. The company has a market cap of $8.638 billion and a P/E ratio of 21.03.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings results on Wednesday, July 23rd. The company reported $1.08 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.09 by $0.01. The company had revenue of $747.70 million for the quarter, compared to the consensus estimate of $767.52 million. During the same quarter last year, the company posted $1.03 earnings per share. Varian Medical Systems’s revenue was up 3.0% compared to the same quarter last year. On average, analysts predict that Varian Medical Systems will post $4.27 earnings per share for the current fiscal year.

VAR has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note on Friday, July 25th. They now have a $88.00 price target on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, July 24th. They now have a $98.00 price target on the stock, up previously from $92.00. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Varian Medical Systems in a research note on Thursday, July 24th. They now have a $95.00 price target on the stock, up previously from $85.00. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $87.22.

Varian Medical Systems, Inc, is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.